Skip to main content
. Author manuscript; available in PMC: 2016 Nov 10.
Published in final edited form as: Int J Pharm. 2015 Sep 15;495(1):393–403. doi: 10.1016/j.ijpharm.2015.08.089

Table 1. Variables and responses from the central composite design.

Variables Responses

Run # Type of Design Point Total Amount of PLGA (mg) DLG7E Ratio (%) Dexamethasone (mg) Drug Loading (%) Burst Release (%) Encapsulatin Efficiency (%)
CCD-1 Star 500.00 20.00 75.00 9.71 37.21 74.44
CCD-2 Edge 559.46 83.78 60.13 9.29 10.26 95.73
CCD-3 Star 500.00 60.00 100.00 13.36 13.71 80.16
CCD-4 Edge 559.46 83.78 89.87 13.18 10.33 95.23
CCD-5 Edge 559.46 36.22 89.87 11.19 30.13 80.85
CCD-6 Star 500.00 60.00 50.00 8.66 12.10 95.26
CCD-7 Center 500.00 60.00 75.00 12.12 18.92 92.92
CCD-8 Star 400.00 60.00 75.00 12.13 21.08 76.82
CCD-9 Center 500.00 60.00 75.00 11.47 17.93 87.94
CCD-10 Edge 440.54 83.78 60.13 11.25 9.75 93.67
CCD-11 Center 500.00 60.00 75.00 11.55 17.87 88.55
CCD-12 Center 500.00 60.00 75.00 11.21 15.17 85.94
CCD-13 Edge 440.54 36.22 89.87 14.32 35.20 84.52
CCD-14 Edge 559.46 36.22 60.13 8.77 15.20 90.37
CCD-15 Star 500.00 100.00 75.00 12.84 5.18 98.44
CCD-16 Center 500.00 60.00 75.00 11.32 14.28 86.79
CCD-17 Star 600.00 60.00 75.00 9.81 14.27 88.29
CCD-18 Edge 440.54 83.78 89.87 15.90 12.10 93.84
CCD-19 Edge 440.54 36.22 60.13 11.23 20.47 93.51
CCD-20 Center 500.00 60.00 75.00 12.41 15.38 95.14